Latest Industry News & Trends
Market Scope provides comprehensive coverage of the ophthalmic market. Our news stories are a combination of public and proprietary content ranging from coverage of international meetings, surgeon survey results and trends, analysis of company financial reports and public medical registries, press releases, and interviews with executives. Register today to receive free weekly email updates, our top data chart, surgeon poll results, and much more. Locked content can be accessed through a subscription to our ophthalmic industry newsletters.
MIGS News
Iantrek Announces US Commercial Launch of AlloFlo Uveo Biostent
Iantrek announced Oct. 14 the US commercial launch of the AlloFlo Uveo, a novel minimally invasive glaucoma surgical (MIGS) device targeting the uveoscleral drainage pathway. The AlloFlo Uveo allog...
Nova Eye’s iTrack Advance Canaloplasty Device Approved in China
Australia’s Nova Eye Medical announced Sept. 30 that China’s National Medical Products Administration had approved the marketing of the company’s iTrack Advance canaloplasty device for glaucoma. Th...
Attendees in Copenhagen Debate Whether Lasers Will Replace MIGS Stents
Panel sessions at the 2025 Ophthalmology Futures Forum and ESCRS Glaucoma Subspecialty Day brought together leading experts to debate the future of MIGS stents and whether lasers could emerge as a ...
Emerging Companies Pursuing Ophthalmic Indications, October 2025
Market Scope is tracking companies that have announced new candidates to diagnose and treat eye disease.
October 2025 Ophthalmic News Briefs
Biotech Healthcare announced Sept. 23 that it had launched the Optiflex Xtense Comfort Plus extended-depth-of-focus (EDOF) intraocular lens at the ESCRS 2025 congress in Copenhagen, Denmark. Biotec...
Iantrek Announces US Commercial Launch of AlloFlo Uveo Biostent for Glaucoma
Iantrek announced Oct. 14 the US commercial launch of the AlloFlo Uveo, a novel minimally invasive glaucoma surgical (MIGS) device targeting the uveoscleral drainage pathway. The AlloFlo Uveo allog...
US FDA Gives Green Light to Trial of Avisi’s VisiPlate Aqueous Shunt for Glaucoma
Avisi Technologies announced Oct. 14 that the US FDA had signed off on its investigational device exemption (IDE) submission, allowing the company to proceed with a trial of the VisiPlate aqueous s...
Ciliatech’s Intercil Uveal Spacer for Glaucoma Gains CE Marking
France’s Ciliatech announced Aug. 27 that European regulators had granted CE marking for the Intercil Uveal Spacer, a surgical implant for glaucoma. The Intercil, also known as the cilioscleral int...
Novel Subconjunctival Devices Expected to Improve Treatment for More Advanced Glaucoma Patients
Improved glaucoma surgical devices and lasers are expected to drive healthy growth in procedure volume over the next five years. Subconjunctival devices, in particular, could alter the prospects fo...
Myra Vision Gains IDE Approval to Begin US Trial of Adjustable Glaucoma Shunt
Myra Vision announced Aug. 12 that the US FDA had issued a conditional approval letter for its investigational device exemption (IDE) application to initiate a US trial of its Calibreye titratable ...
New World Medical Launches New Streamline with Transparent Tip
New World Medical announced May 14 the launch of an enhanced Streamline viscodilation handpiece for glaucoma surgery, featuring a transparent tip designed for improved visualization of key anatomic...
New World Medical Launches New Streamline with Transparent Tip
New World Medical announced May 14 the launch of an enhanced Streamline viscodilation handpiece for glaucoma surgery, featuring a transparent tip designed for improved visualization of key anatomic...
Indian Glaucoma Surgeons Embrace MIGS Procedures Over Devices
Most MIGS (minimally invasive glaucoma surgery) sessions at major ophthalmic meetings talk about devices. Indian doctors at the MIGS sessions of the joint APAO-AIOS congress in April mostly talked ...
Select US FDA Approvals and Clearances in February 2025
There was one US FDA clearance through the ophthalmic device division using the 510(k) pathway in February 2025, according to the agency’s database. New World Medical gained clearance of its Via360...
New World Medical Gains US Clearance for the Via360 Viscodilation System for Glaucoma
New World Medical announced Feb. 18 that it had received 510(k) clearance from the US FDA for its Via360 glaucoma surgical system. The Rancho Cucamonga, California, company said the device would be...
2024 Ophthalmic Revenue Roundup for Apellis, Immunocore, Sight Sciences, Ocular Therapeutix, Lensar, and ANI
Apellis Pharmaceuticals, of Waltham, Massachusetts, reported Feb. 28 that its 2024 net product revenue for Syfovre was $611.8 million, a 122.3 percent increase over $275.2 million in 2023. The comp...
MACs Finalize Coverage for Standalone and Combo MIGS Procedures
Five Medicare administrative contractors have issued their final coverage policies for minimally invasive glaucoma surgery, or MIGS, along with more technical billing and coding documents. The poli...
MACs Finalize Coverage for Standalone and Combo MIGS Procedures
Five Medicare administrative contractors have issued their final coverage policies for minimally invasive glaucoma surgery, or MIGS, along with more technical billing and coding documents. The poli...
iStar Medical Appoints Richard Beckman, MD, as Chief Medical Officer
Belgium’s iStar Medical announced Sept. 4 that it had appointed Richard Beckman, MD, as chief medical officer and member of the company’s board. Beckman most recently served as CMO of Adverum Biote...
Want to Read the Full Article?
Already Have an Account?
Register A Corporate Account
A corporate account gives you access to licensed reports and subscriptions, the latest news, a personalized dashboard, and weekly emails with news and data.